Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement

American Journal of Hematology

Volumn 77, Issue 2, 2004, Pages 144-146

  Asatiani, Ekatherine ^a   Cohen, Philip ^a   Ozdemirli, Metin ^a   Kessler, Craig M ^a   Mavromatis, Blanche ^a   Cheson, Bruce D ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

ENMZL; Extranodal marginal zone lymphoma; Monoclonal gammopathy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; EXTRANODAL MARGINAL ZONE LYMPHOMA; FISHER EXACT TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MUCOSA; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPLEEN;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; NEOPLASM STAGING; PARAPROTEINEMIAS; RETROSPECTIVE STUDIES;

EID: 4644225383     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20157     Document Type: Article

References (11)

1. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86.
2. Ott MM, Rosenwald A, Katzenberger T, et al. Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities. Genes Chromosomes Cancer 2000;28:380-386.
3. Cortelazzo S, Rossi A, Roggero F, et al. Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG). Ann Oncol 1999;10:1433-1440.
4. Castrillo JM, Montalban C, Abraira V, et al. Evaluation of the international index in the prognosis of high grade gastric malt lymphoma. Leuk Lymphoma 1996;24:159-163.
5. Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol 1999;36:148-154.
6. Economopoulos T, Papageorgiou S, Pappa V, et al. Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas. Leuk Res 2003;27:505-508.
7. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification [abstract]. Cancer Res 1971;11:1860-1861.
8. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994.
9. Deegan MJ, Abraham JP, Sawdyk M, Van Slyck EJ. High incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients. Blood 1984;64:1207-1211.
10. Valdez R, Finn WG, Ross CW, et al. Waldenstrom macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases. Am J Clin Pathol 2001;116:683-690.
11. Nakata M, Matsuno Y, Takenaka T, et al. B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma. Int J Hematol 1997;65:405-411.